Charles River Laboratories CRL Manufacturing — D&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's manufacturing — d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Charles River Laboratories's manufacturing — D&A?
- Charles River Laboratories (CRL) reported manufacturing — D&A of $8.4M in Q1 2026.
- How has Charles River Laboratories's manufacturing — D&A changed year-over-year?
- Charles River Laboratories's manufacturing — D&A decreased by 84.6% year-over-year, from $54.62M to $8.4M.
- What is the long-term trend for Charles River Laboratories's manufacturing — D&A?
- Over 2 years (2023 to 2025), Charles River Laboratories's manufacturing — D&A has grown at a 32.4% compound annual growth rate (CAGR), from $79.98M to $140.22M.
- What does manufacturing — D&A mean?
- The total non-cash expense representing the wear and tear of physical assets and the expiration of intangible assets within the manufacturing segment. It is a key component in reconciling net income to cash flow.